1Assistant Professor, Dept. of Ophthalmology, Regional Institute of Ophthalmology, PGIMS, Rohtak
2Associate Professor, Dept. of Ophthalmology, Regional Institute of Ophthalmology, PGIMS, Rohtak
3Professor, Dept. of Ophthalmology, Regional Institute of Ophthalmology, PGIMS, Rohtak
4Junior Resident, Dept. of Ophthalmology, Regional Institute of Ophthalmology, PGIMS, Rohtak
*Corresponding Author: Email: drjitenderphogat@gmail.com
Online published on 14 June, 2017.
Comparison of topical Bromfenac versus topical Prednisolone acetate to control post cataract surgery ocular inflammation.
Effectiveness and safety of topical Bromfenac(0.09%) and topical Prednisolone acetate (1%) was evaluated in patients of cataract surgery in controlling inflammation. Two groups of patients each having 100 patients were enrolled in this study. Both the groups were comparable in baseline parameters. Patients in each group were followed for one month after cataract surgery. Visual acuity, post-operative inflammation was evaluated by detailed slit-lamp examination in both groups at first day, one week and one month after the surgery.
The two groups had no statistically significant difference in post-operative inflammation and were well tolerated.
Bromfenac(0.09%) is an effective drug in controlling ocular inflammation after un-complicated cataract surgery having effect comparable to topical Prednisolone acetate(1%) with minimal side effects.
Bromfenac, Cataract, Inflammation, Prednisolone
